enalapril has been researched along with Pneumonia--Viral* in 2 studies
2 other study(ies) available for enalapril and Pneumonia--Viral
| Article | Year |
|---|---|
Facts and reflections on COVID-19 and anti-hypertensives drugs.
Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it. Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Enalapril; Humans; Hypertension; Losartan; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Virus Internalization | 2020 |
Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.
Topics: Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Enalapril; Losartan; Male; Mice; Mice, Inbred C57BL; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; RNA, Messenger; SARS-CoV-2; Serine Endopeptidases; Tissue Distribution | 2020 |